Hyperleukocytosis is a hematologic crisis caused by excessive proliferation of leukemic cells
and has a relatively high early mortality due to a series of severe complications. Therefore …

Blood apheresis technologies are crucial during blood donation and toxin removal. Current
purification methods such as leukocytapheresis, erythrocytapheresis, thrombocytapheresis …

Circulating tumor cells (CTCs) detected by CellSearch are prognostic in non-small-cell lung
cancer (NSCLC), but rarely found. CTCs can be extracted from the blood together with …

Background aims The most widely accepted starting materials for chimeric antigen receptor
T-cell manufacture are autologous CD3+ T cells obtained via the process of leukapheresis …

Apheresis is at the forefront of therapeutic approaches for an increasing number of
indications caused by formation of pathologic antibodies treated by therapeutic plasma …

Abstract Background Circulating tumour cells (CTCs) can be used to monitor cancer
longitudinally, but their use in non-small cell lung cancer (NSCLC) is limited due to low …

Simple Summary We retrospectively reviewed data from cancer patients undergoing
peripheral blood stem cell (PBSC) collection following different mobilization regimens (with …

In the clinical setting, a blood sample is typically the starting point for biomarker search and
discovery. Mass spectrometry (MS) is a highly sensitive and informative method for …

Background: The major drug regulatory agencies have approved chimeric antigen receptor
(CAR) T cells for the treatment of some B-cell lymphoproliferative diseases. Their use is …

Background aims For patients needing allogeneic stem cell transplantation but lacking a
major histocompatibility complex (MHC)-matched donor, haplo-identical (family) donors may …